Simon Tang

Registration is now open for our 5th July online seminars in protein & peptide science from Chiara Maniaci (@chiaramaniaci) and Simon Tang (@TM_Simon_Tang) rsc.org/events/detail/…

Great to get this one out there! Recombinant cyclic protein production using intercellular AEP catalysis

Happy to be involved with this project working with Sapience Tx. Exponential Combination of a and e/g Intracellular Peptide Libraries Identifies a Selective ATF3 Inhibitor | ACS Chemical Biology ⁦@JodyMMason⁩ ⁦@UniofBathSci⁩ pubs.acs.org/doi/10.1021/ac…

I have a fully funded PhD studentship focused on the development of covalent radioligands: findaphd.com/phds/project/s…. If you have home fee status, are passionate about cancer drug discovery and love peptides then please apply. Deadline = 28th Jan.

Looking forward to our next career speaker Dr Aswin Doekhie, CTO and co-founder at EnsiliTech on Thursday 25th - Milner Centre – Seminar room

Scientists harness flower 'super power' to pave the way for new #drugTreatments @UniOfBath doi.org/gs6znq phys.org/news/2023-11-s…

Happy to get the opportunity to present my work at @AusPeptide in Brisbane. I had a great time listening to some fantastic talks and chatting all things peptide #AusPeptide2023

Very happy to have presented my continued work on peptide library screening and TF inhibition at the International Peptide Symposium @AusPeptide yesterday. An incredible community of scientists, I’m proud to be a part of #AusPeptide2023

Delighted to present our work on in cellulo library-derived peptides to target alpha-synuclein aggregation and toxicity at the 2023 international peptide symposium @auspeptide @ARC_CIPPS #AusPeptide2023

This year the University of Bath has organised a series of events to celebrate the Postdoc Appreciation Week (18th - 22nd September) and acknowledge postdoc work over the year! Details and event registration at this link: bath.ac.uk/events/postdoc… #LovePostdocs #NPAW2023

Preparing recombinant “Split AEP” for protein labeling sciencedirect.com/science/articl…

a-Synuclein misfolding is associated with numerous neurodegenerative diseases, with the first 25 residues (aS 1–25) representing a suitable template for inhibitor design. Meade et al. report that aS 1–25 binds lipids and prevent aS binding in a dose-dependent manner, offering a potential mechanistic route for therapeutic intervention. @jodymmason @Sc0ttAll3n @TM_Simon_Tang @UniOfBath @BristolUni cell.com/cell-reports-p…